Xianding Wang

Dr. Xianding Wang


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2024 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
YXYang Xiong
Yang Xiong
QZQian Zhong
Qian Zhong
YZYangchang Zhang
Yangchang Zhang
ZLZhihong Liu
Zhihong Liu
XWXianding Wang
Xianding Wang
Introduction: Circadian syndrome (CircS) is proposed as a novel risk cluster based on reduced sleep duration, abdominal obesity, depression, hypertension, dyslipidemia and hyperglycemia. However, the association between CircS and chronic kidney disease (CKD) remains unclear. To investigate the cross-sectional and longitudinal association between CircS and CKD, this study was performed.Methods: A national prospective cohort (China Health and Retirement Longitudinal Study, CHARLS) was used in this study. To define CKD, the estimated glomerular filtration rate (eGFR) was calculated based on the 2012 CKD-EPI creatinine-cystatin C equation. Participants with eGFR <60 mL.min-1/1.73/m2 were diagnosed with CKD. Multivariate binary logistic regression was used to assess the cross-sectional association between CircS and CKD. Subgroup and interactive analyses were performed to determine the interactive effects of covariates. In the sensitivity analysis, the obese population was excluded and another method for calculating the eGFR was used to verify the robustness of previous findings. In addition, participants without CKD at baseline were followed up for four years to investigate the longitudinal relationship between CircS and CKD.Results: A total of 6355 participants were included in this study. In the full model, CircS was positively associated with CKD (OR = 1.28, 95% CI = 1.04-1.59, P < 0.05). As per one increase of CircS components, there was a 1.11-fold (95% CI = 1.04-1.18, P < 0.05) risk of prevalent CKD in the full model. A significant interactive effect of hyperuricemia in the CircS-CKD association (P for interaction < 0.01) was observed. Sensitivity analyses excluding the obese population and using the 2009 CKD-EPI creatinine equation to diagnose CKD supported the positive correlation between CircS and CKD. In the 2011-2015 follow-up cohort, the CircS group had a 2.18-fold risk of incident CKD (95% CI = 1.33-3.58, P < 0.01) in the full model. The OR was 1.29 (95% CI = 1.10-1.51, P < 0.001) with per one increase of CircS components.Conclusion: CircS is a risk factor for CKD and may serve as a predictor of CKD for early identification and intervention.

21 May 2024 in Heliyon
Verified
Journal Article
Open access
YXYang Xiong
Yang Xiong
TWTianhong Wang
Tianhong Wang
WWWei Wang
Wei Wang
YZYangchang Zhang
Yangchang Zhang
FZFuxun Zhang
Fuxun Zhang
XWXianding Wang
Xianding Wang
Chronic kidney disease (CKD) is prevalent globally with limited therapeutic drugs available. To systemically identify novel proteins involved in the pathogenesis of CKD and possible therapeutic targets, we integrated human plasma proteomes with the genome-wide association studies (GWASs) of CKD, estimated glomerular filtration rate (eGFR) and blood urea nitrogen (BUN) to perform proteome-wide association study (PWAS), Mendelian Randomization and Bayesian colocalization analyses. The single-cell RNA sequencing data of healthy human and mouse kidneys were analyzed to explore the cell-type specificity of identified genes. Functional enrichment analysis was conducted to investigate the involved signaling pathways. The PWAS identified 22 plasma proteins significantly associated with CKD. Of them, the significant associations of three proteins (INHBC, LMAN2, and SNUPN) were replicated in the GWASs of eGFR, and BUN. Mendelian Randomization analyses showed that INHBC and SNUPN were causally associated with CKD, eGFR, and BUN. The Bayesian colocalization analysis identified shared causal variants for INHBC in CKD, eGFR, and BUN (all PP4 > 0.75). The single-cell RNA sequencing revealed that the INHBC gene was sparsely scattered within the kidney cells. This proteomic study revealed that INHBC, LMAN2, and SNUPN may be involved in the pathogenesis of CKD, which represent novel therapeutic targets and warrant further exploration in future research.

22 November 2024 in Journal of Global Health
Verified
Journal Article
Open access
SLShengzhuo Liu
Shengzhuo Liu
XLXiaoyang Liu
Xiaoyang Liu
PSPan Song
Pan Song
LYLuchen Yang
Luchen Yang
ZLZhenghuan Liu
Zhenghuan Liu
DQDong Qiang
Dong Qiang
Benign prostatic hyperplasia (BPH) is distinguished by symptoms such as urinary incontinence and retention, standing as the most prevalent urologic condition among older men. Its onset typically becomes evident upon reaching the age of 45, with a discernible increase in incidence over time, with approximately 25% of men in their fifties, 33% among those in […]

13 May 2024 in Endocrine Research
Verified
Journal Article
Closed access
YXYang Xiong
Yang Xiong
XJXue Jiang
Xue Jiang
QZQian Zhong
Qian Zhong
YZYangchang Zhang
Yangchang Zhang
HZHaowen Zhang
Haowen Zhang
XWXianding Wang
Xianding Wang
Chronic kidney disease (CKD) is a chronic metabolic disorder characterized by the gradual loss of renal excretory and endocrine functions.1 In most highly resourced countries, the overall prevalenc...

4 November 2025 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
SLShengzhuo Liu
Shengzhuo Liu
YYYunfei Yu
Yunfei Yu
JZJing Zhou
Jing Zhou
LYLucheng Yang
Lucheng Yang
XYXin Yan
Xin Yan
QDQiang Dong
Qiang Dong
Synopsis: Tertiary lymphoid structures (TLSs) are linked to better outcomes in prostate cancer. Neoadjuvant hormone therapy enhances TLS formation, immune cell infiltration, and tumor response—supporting the potential of combining hormone and immunotherapy for improved treatment. Purpose: This study investigates the characteristics and prognostic significance of tertiary lymphoid structures (TLS) in prostate cancer (PCa), and explores the impact of neoadjuvant hormone therapy (NHT) on TLS formation and maturation. Materials and methods: TLS features and immune infiltration were assessed in PCa cohorts using H&E and multiplex immunohistochemistry (mIHC) for Ki67, panCK, CD21, CD4, CD8, and CD20. Public datasets compared TLS signatures between NHT-treated and NHT-naïve patients, and between paired pre-/post-NHT samples. An orthotopic immunocompetent PCa mouse model was generated using organoids and CRISPR-Cas9. Flow cytometry evaluated immune infiltration in bicalutamide-treated mice, and anti-PD1 was combined with degarelix/bicalutamide in preclinical mouse model. Results: TLS were detected in 93% of NHT-naïve PCa tissues, predominantly within tumors. Mature TLS, secondary follicle-like TLS (SFL-TLS), and higher intra-tumoral TLS density correlated with prolonged progression-free survival (PFS). NHT-treated patients exhibited elevated TLS maturity, density, and immune infiltration (CD4+, CD8+, CD20+, CD21+ cells). Matched biopsies confirmed NHT enhanced TLS detection, maturation, and intra-TLS CD8+ T cell infiltration. Transcriptomics revealed upregulated CD4, CD8, CD20, and FOXP3 post-NHT. In mice, androgen deprivation therapy (ADT) increased immune infiltration, and anti-PD1/ADT combination improved tumor response. Conclusion: Our findings demonstrate that TLS serve as a favorable prognostic biomarker in prostate cancer. NHT enhances TLS formation, maturation, and immune cell infiltration, suggesting a synergistic role for androgen deprivation in shaping the tumor immune microenvironment. The improved anti-tumor response with combined anti-PD1 and ADT highlights the potential of immunotherapy-endocrine therapy combinations as a promising treatment strategy for PCa.

3 August 2025 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
LLLede Lin
Lede Lin
ZLZhihong Liu
Zhihong Liu
YTYaxiong Tang
Yaxiong Tang
TLTao Lin
Tao Lin
XLXiang Li
Xiang Li
XWXianding Wang
Xianding Wang